BrainsWay Ltd. filed an amended Form 6-K/A on October 26, 2026, updating its Annual General Meeting proxy materials after director Dr. David Zacut notified the company he would not stand for re-election to the board due to personal reasons.

Key Highlights

  • Director withdrawal: Dr. David Zacut notified BrainsWay on October 25, 2026, that he does not intend to stand for re-election to the board of directors, citing personal reasons.
  • Original filing amended: The amendment replaces Exhibits 99.1 and 99.2 from the Original Report filed October 21, 2026, restating the Notice and Proxy Statement and the Proxy Card to reflect the change.
  • Meeting date unchanged: The Annual General Meeting of Shareholders remains scheduled for November 25, 2026, at 3:00 p.m. (Israel time) at the company's offices in Jerusalem, Israel.
  • Scope of amendment: According to the filing, the amendment does not purport to amend, update, or restate any other information in the Original Report, or reflect any events that occurred after the Original Report was filed.
  • Signed by CEO: The filing was signed by Hadar Levy, Chief Executive Officer, on October 26, 2026.

BrainsWay Updates AGM Proxy After Zacut Declines Re-Election

BrainsWay Ltd. (NASDAQ:BWAY), a Jerusalem-based foreign private issuer, submitted an amended current report on Form 6-K/A on October 26, 2026, to update proxy materials for its upcoming Annual General Meeting. The amendment was necessitated by a notification received from Dr. David Zacut on October 25, 2026, stating that he does not intend to stand for re-election to the company's board of directors due to personal reasons, according to the filing.

The company had originally filed a Form 6-K on October 21, 2026, announcing the Annual General Meeting scheduled for November 25, 2026, at 3:00 p.m. (Israel time) at 16 Hartum Street, RAD Tower, 14th Floor, Har HaHotzvim, Jerusalem, Israel. The amendment specifically replaces Exhibit 99.1, the Original Notice and Proxy Statement, and Exhibit 99.2, the Original Proxy Card, to reflect the removal of Dr. Zacut from the slate of director candidates.

The filing states explicitly that the amendment "does not, and does not purport to, amend, update or restate the information in the Original Report, or reflect any events that have occurred after the Original Report was originally filed," beyond the changes related to Dr. Zacut's decision. The Form 6-K/A is incorporated by reference into the company's Registration Statements on Form S-8 and Form F-3 previously filed with the SEC.

What Was Disclosed

BrainsWay filed an amended proxy report disclosing that Dr. David Zacut notified the company on October 25, 2026, that he will not seek re-election to the board, prompting revised proxy materials for the November 25, 2026 Annual General Meeting.